NCT01225302View on ClinicalTrials.gov

A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Linifanib

Low dose linifanib (once a day)

DRUG

Linifanib

High dose linifanib (once a day)

DRUG

Carboplatin

Given on Day 1 of every 21-day cycle

DRUG

Paclitaxel

Given on Day 1 of every 21-day cycle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY